These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 3823607

  • 1. Lack of enhanced myelotoxicity with buthionine sulfoximine and sulfhydryl-dependent anticancer agents in mice.
    Soble MJ, Dorr RT.
    Res Commun Chem Pathol Pharmacol; 1987 Feb; 55(2):161-80. PubMed ID: 3823607
    [Abstract] [Full Text] [Related]

  • 2. Lack of enhanced antitumor efficacy for L-buthionine sulfoximine in combination with carmustine, cyclophosphamide, doxorubicin or melphalan in mice.
    Soble MJ, Dorr RT.
    Anticancer Res; 1988 Feb; 8(1):17-22. PubMed ID: 3358633
    [Abstract] [Full Text] [Related]

  • 3. Effect of glutathione depletion by L-buthionine sulfoximine on the cytotoxicity of cyclophosphamide in single and fractionated doses to EMT6/SF mouse tumors and bone marrow.
    Ono K, Shrieve DC.
    J Natl Cancer Inst; 1987 Oct; 79(4):811-5. PubMed ID: 3477662
    [Abstract] [Full Text] [Related]

  • 4. Combined effects of buthionine sulfoximine and cepharanthine on cytotoxic activity of doxorubicin to multidrug-resistant cells.
    Kisara S, Furusawa S, Murata R, Ogata M, Hikichi N, Takayanagi Y, Sasaki K.
    Oncol Res; 1995 Oct; 7(3-4):191-200. PubMed ID: 8555653
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics of buthionine sulfoximine (NSC 326231) and its effect on melphalan-induced toxicity in mice.
    Smith AC, Liao JT, Page JG, Wientjes MG, Grieshaber CK.
    Cancer Res; 1989 Oct 01; 49(19):5385-91. PubMed ID: 2766304
    [Abstract] [Full Text] [Related]

  • 6. Chemosensitization of L-phenylalanine mustard by the thiol-modulating agent buthionine sulfoximine.
    Kramer RA, Greene K, Ahmad S, Vistica DT.
    Cancer Res; 1987 Mar 15; 47(6):1593-7. PubMed ID: 3815359
    [Abstract] [Full Text] [Related]

  • 7. Effects of L-phenylalanine mustard and L-buthionine sulfoximine on murine and human hematopoietic progenitor cells in vitro.
    Du DL, Volpe DA, Grieshaber CK, Murphy MJ.
    Cancer Res; 1990 Jul 01; 50(13):4038-43. PubMed ID: 2354454
    [Abstract] [Full Text] [Related]

  • 8. Cytotoxic effects of glutathione synthesis inhibition by L-buthionine-(SR)-sulfoximine on human and murine tumor cells.
    Dorr RT, Liddil JD, Soble MJ.
    Invest New Drugs; 1986 Jul 01; 4(4):305-13. PubMed ID: 3583642
    [Abstract] [Full Text] [Related]

  • 9. L-Buthionine (S,R) sulfoximine depletes hepatic glutathione but protects against ethanol-induced liver injury.
    Donohue TM, Curry-McCoy TV, Todero SL, White RL, Kharbanda KK, Nanji AA, Osna NA.
    Alcohol Clin Exp Res; 2007 Jun 01; 31(6):1053-60. PubMed ID: 17428293
    [Abstract] [Full Text] [Related]

  • 10. Tissue-specific changes in glutathione and cysteine after buthionine sulfoximine treatment of rats and the potential for artifacts in thiol levels resulting from tissue preparation.
    Standeven AM, Wetterhahn KE.
    Toxicol Appl Pharmacol; 1991 Feb 01; 107(2):269-84. PubMed ID: 1994510
    [Abstract] [Full Text] [Related]

  • 11. SR-2508 plus buthionine sulfoximine or SR-2508 alone: effects on the radiation response and the glutathione content of a human tumor xenograft.
    Lespinasse F, Biscay P, Malaise EP, Guichard M.
    Radiat Res; 1987 Apr 01; 110(1):149-54. PubMed ID: 2951766
    [Abstract] [Full Text] [Related]

  • 12. Buthionine sulfoximine induction of gamma-L-glutamyl-L-cysteine synthetase gene expression, kinetics of glutathione depletion and resynthesis, and modulation of carmustine-induced DNA-DNA cross-linking and cytotoxicity in human glioma cells.
    Ali-Osman F, Antoun G, Wang H, Rajagopal S, Gagucas E.
    Mol Pharmacol; 1996 Jun 01; 49(6):1012-20. PubMed ID: 8649339
    [Abstract] [Full Text] [Related]

  • 13. Effect of doxorubicin on glutathione and glutathione-dependent enzymes in cultured rat heart cells.
    Paranka NS, Dorr RT.
    Anticancer Res; 1994 Jun 01; 14(5A):2047-52. PubMed ID: 7847848
    [Abstract] [Full Text] [Related]

  • 14. Nephrotoxicity of thiazoles structurally related to thiabendazole in mice depleted of glutathione by treatment with buthionine sulfoximine.
    Mizutani T, Yoshida K, Ito K.
    Res Commun Chem Pathol Pharmacol; 1992 Jan 01; 75(1):29-38. PubMed ID: 1626124
    [Abstract] [Full Text] [Related]

  • 15. Enhanced melphalan cytotoxicity following buthionine sulfoximine-mediated glutathione depletion in a human medulloblastoma xenograft in athymic mice.
    Skapek SX, Colvin OM, Griffith OW, Elion GB, Bigner DD, Friedman HS.
    Cancer Res; 1988 May 15; 48(10):2764-7. PubMed ID: 3359437
    [Abstract] [Full Text] [Related]

  • 16. In vivo therapeutic potential of combination thiol depletion and alkylating chemotherapy.
    Siemann DW, Beyers KL.
    Br J Cancer; 1993 Dec 15; 68(6):1071-9. PubMed ID: 8260357
    [Abstract] [Full Text] [Related]

  • 17. Enhancement of cisplatin toxicity by buthionine sulfoximine, a glutathione-depleting agent, in mice.
    Ishikawa M, Takayanagi Y, Sasaki K.
    Res Commun Chem Pathol Pharmacol; 1990 Jan 15; 67(1):131-41. PubMed ID: 2326543
    [Abstract] [Full Text] [Related]

  • 18. Glutathione depletion, radiosensitization, and misonidazole potentiation in hypoxic Chinese hamster ovary cells by buthionine sulfoximine.
    Clark EP, Epp ER, Biaglow JE, Morse-Gaudio M, Zachgo E.
    Radiat Res; 1984 May 15; 98(2):370-80. PubMed ID: 6539482
    [Abstract] [Full Text] [Related]

  • 19. Influence of buthionine sulfoximine and misonidazole on glutathione level and radiosensitivity of human tumor xenografts.
    Guichard M, Lespinasse F, Malaise EP.
    Radiat Res; 1986 Jan 15; 105(1):115-25. PubMed ID: 3945723
    [Abstract] [Full Text] [Related]

  • 20. Pharmacologic modulation of reduced glutathione circadian rhythms with buthionine sulfoximine: relationship with cisplatin toxicity in mice.
    Li XM, Metzger G, Filipski E, Boughattas N, Lemaigre G, Hecquet B, Filipski J, Levi F.
    Toxicol Appl Pharmacol; 1997 Apr 15; 143(2):281-90. PubMed ID: 9144445
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.